HAVANA, June 24 (NNN-Prensa Latina): Thanks to the massive vaccination campaigns carried out in Cuba, the country managed to eradicate acute viral hepatitis type B in children under 15 years.
A national immunogen, Heberbiovac HB, produced by the Center for Genetic Engineering and Biotechnology, which protects for life, has guaranteed the demise of the disease.
In the past 23 years a single case have not been reported of this disease in pediatric patients, stated to the Granma newspaper, Dr. Maira Fonte Reyes, a specialist in Hygiene and Epidemiology and a Masters in Infectious Diseases.
Fonte also highlighted that in this period, acute viral hepatitis B decreased its incidence in the country in 99.04 percent.
Hepatitis B is one of the five viruses identified up to this moment responsible for the liver inflammation, which can become chronic and then cause acute liver failure, cirrhosis and cancer.
Since 1992 one hundred percent of Cuban children began to be vaccinated at birth with anti-hepatitis B and, in successive campaigns, immunization was extended to students and risky groups such as health care workers, dialysis patients, among other.
At this moment the entire population under 31 years is protected against the disease, the report noted.
Given that the infection is acquired by direct contact with blood and other body fluids such as semen, the vaccine is administered in the areas of health to those over 31 years who have not been vaccinated, prior knowledge that they are not carriers of the hepatitis B virus.